Stanolone

Modify Date: 2024-01-02 19:09:47

Stanolone structure	Common Name	Stanolone
	CAS Number	521-18-6	Molecular Weight	290.440
	Density	1.1±0.1 g/cm3	Boiling Point	413.1±38.0 °C at 760 mmHg
	Molecular Formula	C₁₉H₃₀O₂	Melting Point	178-183 °C
	MSDS	Chinese USA	Flash Point	176.4±19.4 °C
	Symbol	GHS02, GHS06, GHS08	Signal Word	Danger

Name	17β-hydroxy-5α-androstan-3-one
Synonym	More Synonyms

Density	1.1±0.1 g/cm3
Boiling Point	413.1±38.0 °C at 760 mmHg
Melting Point	178-183 °C
Molecular Formula	C₁₉H₃₀O₂
Molecular Weight	290.440
Flash Point	176.4±19.4 °C
Exact Mass	290.224579
PSA	37.30000
LogP	3.75
Vapour Pressure	0.0±2.2 mmHg at 25°C
Index of Refraction	1.536

CHEMICAL IDENTIFICATION

RTECS NUMBER :: BV8052000

CHEMICAL NAME :: 5-alpha-Androstan-3-one, 17-beta-hydroxy-

CAS REGISTRY NUMBER :: 521-18-6

LAST UPDATED :: 199206

DATA ITEMS CITED :: 19

MOLECULAR FORMULA :: C19-H30-O2

MOLECULAR WEIGHT :: 290.49

WISWESSER LINE NOTATION :: L E5 B666 OVTJ A1 E1 FQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 17500 ug/kg

SEX/DURATION :: female 35 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Fertility - female fertility index (e.g. # females pregnant per # sperm positive females; # females pregnant per # females mated)

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 160 mg/kg

SEX/DURATION :: female 14-21 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - urogenital system

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 1400 ug/kg

SEX/DURATION :: female 14 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Maternal Effects - uterus, cervix, vagina Reproductive - Fertility - other measures of fertility

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 700 ug/kg

SEX/DURATION :: female 14 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Maternal Effects - ovaries, fallopian tubes

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intramuscular

DOSE :: 80 mg/kg

SEX/DURATION :: female 13-20 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - skin and skin appendages Reproductive - Specific Developmental Abnormalities - urogenital system

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Parenteral

DOSE :: 2500 ug/kg

SEX/DURATION :: female 10 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Maternal Effects - ovaries, fallopian tubes

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Parenteral

DOSE :: 168 mg/kg

SEX/DURATION :: male 1 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - prostate, seminal vesicle, Cowper's gland, accessory glands

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Implant

DOSE :: 24 mg/kg

SEX/DURATION :: male 42 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - testes, epididymis, sperm duct Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Unreported

DOSE :: 150 mg/kg

SEX/DURATION :: female 30 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Maternal Effects - uterus, cervix, vagina

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 40 mg/kg

SEX/DURATION :: female 1 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Maternal Effects - ovaries, fallopian tubes Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Fertility - other measures of fertility

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 40 mg/kg

SEX/DURATION :: female 10 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Maternal Effects - uterus, cervix, vagina Reproductive - Maternal Effects - other effects

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 2 gm/kg

SEX/DURATION :: female 14 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - skin and skin appendages

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 24 mg/kg

SEX/DURATION :: female 3 day(s) after conception

TOXIC EFFECTS :: Reproductive - Maternal Effects - uterus, cervix, vagina

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intramuscular

DOSE :: 200 ug/kg

SEX/DURATION :: male 20 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intramuscular

DOSE :: 14 mg/kg

SEX/DURATION :: male 70 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Implant

DOSE :: 3420 ug/kg

SEX/DURATION :: male 90 day(s) pre-mating

TOXIC EFFECTS :: Reproductive - Paternal Effects - testes, epididymis, sperm duct

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

DOSE :: 30 mg/kg

SEX/DURATION :: female 1-3 day(s) after conception

TOXIC EFFECTS :: Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea)

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Unreported

DOSE :: 1500 ug/kg

SEX/DURATION :: female 1-3 day(s) after conception

TOXIC EFFECTS :: Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea)

MUTATION DATA

TEST SYSTEM :: Non-mammalian species

DOSE/DURATION :: 12 mg/8W (Intermittent)

REFERENCE :: JEZOAO Journal of Experimental Zoology. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1904- Volume(issue)/page/year: 205,403,1978

Symbol	GHS02, GHS06, GHS08
Signal Word	Danger
Hazard Statements	H225-H301 + H311 + H331-H370
Precautionary Statements	P210-P280-P302 + P352 + P312-P304 + P340 + P312-P370 + P378-P403 + P235
Personal Protective Equipment	Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
Hazard Codes	Xn
Risk Phrases	R61
Safety Phrases	S53-S36/37/39-S45
RIDADR	UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany	3
RTECS	BV8052000
Packaging Group	II
Hazard Class	6.1

Precursor 8
CAS#:58701-44-3 17β-TBDMS-dihyd... CAS#:361336-13-2 (5S,8R,9S,10S,1... CAS#:846-46-8 5a-Androstanedione CAS#:1046-35-1 3,3-Aethylendio...
CAS#:91475-95-5 Androstan-3-one... CAS#:58-22-0 Testosterone CAS#:112251-17-9 3,17β-bis-[2,3,... CAS#:75958-96-2 (3R,5S,8R,9S,10...
DownStream 10
CAS#:1827-75-4 Androstan-17-ol... CAS#:481-29-8 Epiandrosterone CAS#:53-41-8 Androsterone CAS#:846-46-8 5a-Androstanedione
CAS#:571-20-0 5α-Androstane-3... CAS#:2384-24-9 (3R,5S,8R,9S,10... CAS#:1852-53-5 5a-Androstane-3... CAS#:571-40-4 (5S,8R,9S,10R,1...
CAS#:27261-27-4 Androstane-3,16... CAS#:121209-70-9 5α-androstane-2...

Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis.

Cancer Res. 75(6) , 1102-12, (2015)

The translation initiation factor eIF4E is an oncogene that is commonly overexpressed in primary breast cancers and metastases. In this article, we report that a pharmacologic inhibitor of eIF4E funct...

Aptamer-based polyvalent ligands for regulated cell attachment on the hydrogel surface.

Biomacromolecules 16(4) , 1382-9, (2015)

Natural biomolecules are often used to functionalize materials to achieve desired cell-material interactions. However, their applications can be limited owing to denaturation during the material funct...

Co-ordinated brain and craniofacial development depend upon Patched1/XIAP regulation of cell survival.

Hum. Mol. Genet. 24(3) , 698-713, (2015)

Congenital brain and craniofacial defects often occur together as a consequence of their developmental dependency on common progenitor tissue interactions and signaling pathways during embryogenesis. ...

Stanolone

EINECS 208-307-3

Anaboleen

17β-Hydroxy-5α-androstane-3-one

Androlone

dihydrotestosterone

Anabolex

(5a,17b)-17-Hydroxyandrostan-3-one

5α-Dihydrotestosterone

Stanorone

5α dihydrotestosterone

Androstanolone

DHT

[14C]-Dihydrotestosterone

Androstan-3-one, 17-hydroxy-, (5α,17β)-

5α-Androstan-3-one, 17β-hydroxy-

[3H]-Dihydrotestosterone

17beta-hydroxy-5alpha-androstan-3-one

Andractim

17β-hydroxy-5α-androstan-3-one

Androstan-17b-ol-3-one

Stanaprol

4-dihydrotestosterone

Neodrol

(5α,17β)-17-Hydroxyandrostan-3-one

5a-Dihydrotestosterone

Protona

Stanolon

Anaprotin

MFCD00003667

Zhejiang Hangyu API Co., Ltd
China
Product Name: Stanolone
Price: ￥Inquiry/1kg
Purity: 99.5%
Stocking Period: Inquiry
Contact: Vinnie

Henan Tianfu Chemical Co., Ltd.
China
Product Name: High Quality Steroid Powder Stanolone / Androstanolone / Dht 521-18-6
Price: $Inquiry/1kg $Inquiry/25kg $Inquiry/1000kg $Inquiry/10ton
Purity: 99.0%
Stocking Period: Inquiry
Contact: Anson

Get all suppliers and price by the below link:

Stanolone suppliers

Stanolone price

Stanolone

Names

Chemical & Physical Properties

Toxicological Information

CHEMICAL IDENTIFICATION

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

Safety Information

Synthetic Route

Precursor & DownStream

Articles2532

Synonyms